Peripheral blood-based <i>S100P</i> hypomethylation as a biomarker for the early-stage non-small cell lung cancer
Using quantitative mass spectrometry, we investigated an association between <i>S100P</i> hypomethylation in peripheral blood and NSCLC and suggested the great potential of DNA methylation signatures in whole blood for early detection of NSCLC.
Authors
- Wanjian Gu (ORCID: https://orcid.org/0000-0003-3781-4668)
- Baohui Han (ORCID: https://orcid.org/0000-0002-3950-3030)
- Rong Qiao (ORCID: https://orcid.org/0009-0001-3668-0162)
- Rongxi Yang (ORCID: https://orcid.org/0000-0002-6655-1986)
- Junjie Li (ORCID: https://orcid.org/0000-0003-4542-300X)
- Wenli Li (ORCID: https://orcid.org/0000-0003-1598-3217)
- Jie Zhang (ORCID: https://orcid.org/0000-0003-2140-3231)
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Chest Hospital (CN)
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Epigenomics
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1080/17501911.2025.2604020
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 0.00